EUROPACE

Scope & Guideline

Transforming research into clinical excellence in cardiology.

Introduction

Explore the comprehensive scope of EUROPACE through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore EUROPACE in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1099-5129
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1999 to 2024
AbbreviationEUROPACE / Europace
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

EUROPACE is a prominent journal focusing on the field of cardiac electrophysiology, particularly emphasizing the management and treatment of arrhythmias through various innovative techniques. The journal serves as a platform for the latest research and clinical practices in electrophysiology, integrating insights from basic science to clinical applications.
  1. Atrial Fibrillation Management:
    Research articles often explore various strategies for the management of atrial fibrillation, including catheter ablation techniques, medical therapies, and the use of new technologies and devices.
  2. Innovative Ablation Techniques:
    The journal features studies on emerging ablation technologies such as pulsed-field ablation and cryoballoon techniques, highlighting their effectiveness and safety in treating arrhythmias.
  3. Electrophysiological Studies and Outcomes:
    A significant focus is placed on the outcomes of electrophysiological studies, including predictive models for arrhythmia recurrence and patient stratification.
  4. Cardiac Devices and Implantable Technologies:
    Research on the development, use, and management of implantable cardioverter-defibrillators (ICDs) and pacemakers, including their programming, complications, and long-term outcomes.
  5. Patient-Centric Approaches:
    Studies addressing patient perspectives, quality of life, and psychosocial factors related to arrhythmia management, emphasizing the importance of holistic care.
  6. Genetic and Molecular Insights:
    Research exploring the genetic basis of arrhythmias and the implications for diagnosis and treatment, contributing to personalized medicine in electrophysiology.
Recent publications in EUROPACE have highlighted several emerging themes that reflect the current trends in cardiac electrophysiology research. These trends indicate a shift towards innovative technologies, patient-centered care, and interdisciplinary approaches.
  1. Pulsed-Field Ablation:
    Pulsed-field ablation has emerged as a key area of research, showcasing its advantages in safety and efficacy compared to traditional ablation methods.
  2. Telemedicine and Remote Monitoring:
    The integration of telehealth solutions and remote monitoring for managing arrhythmias has gained traction, especially highlighted during the COVID-19 pandemic.
  3. Personalized Medicine in Electrophysiology:
    A growing emphasis on personalized approaches to treatment, including genetic testing and individualized risk stratification for arrhythmias.
  4. Hybrid Approaches to Treatment:
    The trend towards hybrid treatment strategies that combine surgical and catheter-based methods for managing complex arrhythmias is becoming increasingly popular.
  5. Focus on Patient Quality of Life:
    Research exploring the psychosocial aspects and quality of life outcomes for patients with arrhythmias is gaining importance, emphasizing comprehensive care.

Declining or Waning

As the field of cardiac electrophysiology evolves, certain themes within EUROPACE have shown signs of declining interest or publication frequency. These waning scopes indicate a shift in focus towards more innovative and contemporary areas of research.
  1. Traditional Antiarrhythmic Drug Studies:
    There has been a noticeable decline in studies focused solely on traditional antiarrhythmic medications, as newer therapies and technologies gain prominence.
  2. Basic Science without Clinical Application:
    Research purely centered on basic electrophysiological mechanisms without direct clinical implications is becoming less common, reflecting a trend towards translational research.
  3. Invasive Procedures without Technological Integration:
    Studies that do not incorporate recent technological advancements in procedures, such as robotic assistance or advanced mapping techniques, are less frequently published.

Similar Journals

HEART AND VESSELS

Exploring Innovations in Cardiology and Vascular Medicine
Publisher: SPRINGERISSN: 0910-8327Frequency: 12 issues/year

HEART AND VESSELS is a prominent peer-reviewed journal published by SPRINGER, dedicated to advancing the fields of cardiology and cardiovascular medicine. With its ISSN 0910-8327 and E-ISSN 1615-2573, this esteemed journal encompasses a broad range of topics pertinent to heart health, vascular function, and associated therapies, making it an essential resource for researchers, clinicians, and healthcare professionals alike. Based in Japan and operating since 1985, HEART AND VESSELS has consistently maintained a Q2 ranking in the 2023 category quartiles, highlighting its relevance and impact in the cardio domain. Although it does not offer open access, the journal ensures high-quality publications that contribute significantly to the academic and clinical understanding of cardiovascular health. With over three decades of continuous scholarly contribution, HEART AND VESSELS serves as a vital platform for disseminating cutting-edge research and fostering innovative practices in the management of cardiovascular diseases.

Circulation-Arrhythmia and Electrophysiology

Leading the charge in electrophysiological advancements.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1941-3149Frequency: 12 issues/year

Circulation-Arrhythmia and Electrophysiology, published by Lippincott Williams & Wilkins, is a premier journal dedicated to advancing the field of cardiology and electrophysiology. With a strong emphasis on clinical and experimental research, this journal serves as a critical platform for disseminating innovative findings concerning arrhythmias and cardiac electrical activity. Operating in a highly competitive academic environment, it boasts an impressive Q1 ranking in key categories such as Cardiology and Cardiovascular Medicine, as well as Physiology (medical), positioning it within the top tier of publications in these fields. Spanning a comprehensive converged period from 2008 to 2024, Circulation-Arrhythmia and Electrophysiology offers researchers and clinicians access to cutting-edge studies that inform best practices and influence treatment protocols. Although it does not provide open access options, it remains invaluable for professionals seeking to enhance their understanding of complex electrophysiological phenomena and contribute to the evolution of cardiovascular care.

Cardiology Journal

Championing open access to vital cardiology research.
Publisher: VIA MEDICAISSN: 1897-5593Frequency: 6 issues/year

Cardiology Journal, published by VIA MEDICA, stands as a prominent resource in the field of cardiology and cardiovascular medicine, with an ISSN of 1897-5593 and an E-ISSN of 1898-018X. Recognized for its Open Access model established since 1994, this journal facilitates widespread dissemination of critical research findings, allowing practitioners and researchers globally to access valuable insights without barriers. Based in Poland, with an address at UL SWIETOKRZYSKA 73, 80-180 GDANSK, it has achieved a respectable Q2 classification in 2023 for both Cardiology and Miscellaneous Medicine categories, reflecting its influence and quality within the scholarly community. With a Scopus ranking placing it at #117 out of 387 in Cardiology, it lies within the 69th percentile, underpinning its commitment to advancing knowledge in cardiovascular health. The journal’s converged years extending from 2006 to 2024 ensure it captures ongoing developments in a rapidly evolving field. As such, the Cardiology Journal serves as an indispensable platform for researchers, professionals, and students dedicated to exploring the frontiers of cardiac science and improving patient care.

Cardiology Research and Practice

Pioneering discoveries in cardiovascular medicine.
Publisher: HINDAWI LTDISSN: 2090-8016Frequency: 1 issue/year

Cardiology Research and Practice is a leading academic journal dedicated to advancing knowledge in the fields of cardiology and cardiovascular medicine. Published by HINDAWI LTD, this journal has been an inclusive platform for open access research since 2009, facilitating the dissemination of high-quality studies that contribute to the global scientific community. With an impact factor placing it in Q2 of its category in 2023, it underscores its importance in delivering innovative insights and discoveries that shape clinical practices and policies. The journal covers a broad scope of topics including, but not limited to, cardiovascular disease prevention, innovative treatment modalities, and emerging technologies, appealing to researchers, healthcare professionals, and students alike. Located in the United States with its international reach, Cardiology Research and Practice serves as a critical resource for those dedicated to improving patient outcomes and advancing the field of cardiology.

ACTA CARDIOLOGICA

Illuminating the path to better cardiovascular care.
Publisher: TAYLOR & FRANCIS LTDISSN: 0001-5385Frequency: 6 issues/year

ACTA CARDIOLOGICA is a distinguished journal published by TAYLOR & FRANCIS LTD, focusing on the dynamic fields of Cardiology and Cardiovascular Medicine. Established in 1946, the journal has maintained a significant presence in the academic community, providing a platform for cutting-edge research and clinical studies that aim to address challenges in cardiovascular health. With its Q3 rating in both Cardiology and General Medicine categories, it showcases a robust compilation of articles that reflect the evolving landscape of cardiac care. Although ACTA CARDIOLOGICA is not an Open Access journal, it continues to serve a vital role for researchers, professionals, and students dedicated to advancing knowledge in cardiovascular health. This journal, with an ISSN of 0001-5385 and E-ISSN of 1784-973X, is a critical resource for those looking to stay updated on the latest developments and practices in the specialization, contributing significantly to the field until 2024 and beyond.

Heart International

Connecting researchers and clinicians in the pursuit of heart health.
Publisher: TOUCH MEDICAL MEDIA LTDISSN: 2036-2579Frequency: 2 issues/year

Heart International is a prominent open-access journal dedicated to the fields of cardiology and cardiovascular medicine, published by TOUCH MEDICAL MEDIA LTD since 2006. Based in Italy, this journal serves as a vital platform for researchers, clinicians, and students, aiming to disseminate cutting-edge scientific findings and clinical insights that advance the understanding of heart health. With an ISSN of 2036-2579 and an emphasis on accessible content, Heart International ensures that valuable research is available to a wide audience, thereby contributing to the global discourse on cardiovascular issues. Although it currently holds a Q4 quartile ranking in its category and is positioned in the lower percentile for Scopus rankings, the journal is committed to improving its impact through rigorous peer review and high-quality publications. The journal covers a wide array of topics within the cardiology domain, making it an essential resource for those looking to stay abreast of the latest developments in heart research.

CURRENT OPINION IN CARDIOLOGY

Exploring the forefront of cardiovascular innovation.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0268-4705Frequency: 6 issues/year

CURRENT OPINION IN CARDIOLOGY, published by LIPPINCOTT WILLIAMS & WILKINS, is an esteemed journal in the field of cardiology that has been serving the academic community since 1988. With a robust focus on the latest developments and emerging trends in cardiovascular medicine, this journal aims to bridge the gap between clinical practice and research, offering critical insights and expert commentary. The journal is recognized in the medical community, achieving a 2023 Scopus rank of #148 out of 387 in its category, placing it in the 61st percentile. Although it operates under a subscription-based model, CURRENT OPINION IN CARDIOLOGY remains an essential resource for researchers, practitioners, and students seeking cutting-edge knowledge and advancements in cardiology. As a Q2 journal in the field, it continues to foster dialogue and provide a platform for disseminating impactful cardiovascular research, ultimately contributing to improved patient outcomes and informed clinical decisions.

Cardiovascular Innovations and Applications

Innovating today for the cardiology breakthroughs of tomorrow.
Publisher: COMPUSCRIPTISSN: 2009-8618Frequency: 1 issue/year

Cardiovascular Innovations and Applications is a premier open-access journal dedicated to advancing knowledge in the field of cardiovascular medicine. Published by COMPUSCRIPT since 2016, this journal provides a platform for the dissemination of innovative research and applications that address crucial topics in cardiology, aiming to bridge the gap between clinical practice and cutting-edge research. With an ISSN of 2009-8618 and an E-ISSN of 2009-8782, it operates on a global scale, facilitating access to high-quality content without financial barriers. The journal is positioned within the Medicine - Cardiology and Cardiovascular Medicine category, and its current Scopus rank of #321/387 reflects its potential for growth and influence in the academic community, being in the 17th percentile. Researchers, healthcare professionals, and students will find Cardiovascular Innovations and Applications an invaluable resource in their quest for the latest findings and advancements in cardiovascular health and treatment methodologies.

Journal of Cardiology

Elevating understanding of cardiovascular diseases globally.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

IJC Heart & Vasculature

Connecting Clinicians and Researchers in Cardiovascular Medicine
Publisher: ELSEVIER IRELAND LTDISSN: Frequency: 4 issues/year

IJC Heart & Vasculature is a premier open-access journal published by Elsevier Ireland Ltd, dedicated to advancing research in the fields of cardiology and cardiovascular medicine. Since its inception in 2013, this journal has established itself as a valuable resource for clinicians, researchers, and students keen on exploring the latest developments in heart and vascular health. With an impressive impact factor and ranked within Q2 in its category (2023), IJC Heart & Vasculature has achieved a significant Scopus rank of #125 out of 387, placing it in the 67th percentile of cardiology journals. The journal not only emphasizes high-quality research but also promotes innovative studies that can shape clinical practices and improve patient outcomes. Researchers and professionals can access a plethora of peer-reviewed articles, original research, and comprehensive reviews that unravel the complexities of cardiovascular science. With a commitment to fostering open and impactful dialogue in the field, IJC Heart & Vasculature is poised to be an essential platform for knowledge exchange in the evolving landscape of cardiovascular research.